William Holland
- Pulmonary and Respiratory Medicine top 10%
- Oncology top 10%
- Molecular Biology
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- Philip C. MackDavid R. GandaraPrimo N. LaraAngela M. DaviesPaul H. GumerlockRebekah A. BurichHenry Jay FormanHongqiao Zhang
- Topics
- Lung Cancer Treatments and Mutations (12 papers)Cancer Genomics and Diagnostics (8 papers)Colorectal Cancer Treatments and Studies (6 papers)
- Journals
- Journal of Clinical OncologyFree Radical Biology and MedicineJournal of Investigative Dermatology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
William Holland
32 papers receiving 524 citations
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 260
- Oncology 260
- Molecular Biology 258
- Cancer Research 95
- Pathology and Forensic Medicine 44
Countries citing papers authored by William Holland
This map shows the geographic impact of William Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Holland more than expected).
Fields of papers citing papers by William Holland
This network shows the impact of papers produced by William Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Holland. The network helps show where William Holland may publish in the future.
Co-authorship network of co-authors of William Holland
This figure shows the co-authorship network connecting the top 25 collaborators of William Holland. A scholar is included among the top collaborators of William Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Holland. William Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 34 | |
| 3 | 15 | |
| 4 | 26 | |
| 5 | 24 | |
| 6 | DIVERGENT ACTIVITY OF AFATINIB (AFAT) AND CETUXIMAB (CET) IN PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF ACQUIRED ERLOTINIB RESISTANCE. | 2 |
| 7 | 16 | |
| 8 | 14 | |
| 9 | 17 | |
| 10 | 61 | |
| 11 | 56 | |
| 12 | 21 | |
| 13 | 1 | |
| 14 | 19 | |
| 15 | 2 | |
| 16 | 15 | |
| 17 | 5 | |
| 18 | 3 | |
| 19 | 7 | |
| 20 | 39 |
About William Holland
William Holland is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 33 papers that have together received 537 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Cancer Genomics and Diagnostics (8 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (260 citations), Pulmonary and Respiratory Medicine (260 citations) and Cancer Research (95 citations). William Holland has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Philip C. Mack, David R. Gandara, Primo N. Lara, Angela M. Davies, Paul H. Gumerlock, Rebekah A. Burich, Henry Jay Forman, Hongqiao Zhang, Dashnamoorthy Ravi and Kumuda C. Das. Their work appears in journals such as Journal of Clinical Oncology, Free Radical Biology and Medicine and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.